Back
Regeneron Pharmaceuticals Stock Price Chart
Sponsored
REGN
Sponsored
Time-Waster to Money-Maker: Join Mode Mobile's $1T Revolution
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
44
REGN
Regeneron Pharmaceuticals
Last Price:
754.51
Seasonality Move:
21.03%
7 Day Trial
ALL ACCESS PASS
$
7
32,481% Growth: Invest in the Smartphone Revolution @ $0.26/Share
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REGN is experiencing buying pressure, which is a positive indicator for future bullish movement.
Regeneron Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 751.48 | Buy |
20-day SMA: | 773.31 | Sell |
50-day SMA: | 894.06 | Sell |
200-day SMA: | 994.55 | Sell |
8-day EMA: | 755.14 | Sell |
20-day EMA: | 784.37 | Sell |
50-day EMA: | 874.28 | Sell |
200-day EMA: | 958.6 | Sell |
Regeneron Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -42.53 | Sell |
Relative Strength Index (14 RSI): | 28.68 | Sell |
Chaikin Money Flow: | 470294 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (743.49 - 834.83) | Sell |
Bollinger Bands (100): | (865.46 - 1158.48) | Sell |
Regeneron Pharmaceuticals Technical Analysis
Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Regeneron Pharmaceuticals Stock
Is Regeneron Pharmaceuticals Stock a Buy?
- Regeneron Pharmaceuticals share price is 754.26 while REGN 8-day simple moving average is 751.48, which is a Buy signal.
- The stock price of REGN is 754.26 while Regeneron Pharmaceuticals 20-day SMA is 773.31, which makes it a Sell.
- Regeneron Pharmaceuticals 50-day simple moving average is 894.06 while REGN share price is 754.26, making it a Sell technically.
- REGN stock price is 754.26 and Regeneron Pharmaceuticals 200-day simple moving average is 994.55, creating a Sell signal.
REGN Technical Analysis vs Fundamental Analysis
Sell
44
Regeneron Pharmaceuticals (REGN)
is a Sell
Is Regeneron Pharmaceuticals a Buy or a Sell?
-
Regeneron Pharmaceuticals stock is rated a Sell
The current Regeneron Pharmaceuticals [REGN] share price is $754.26. The Score for REGN is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
Regeneron Pharmaceuticals Stock Info
Market Cap:
82.89B
Price in USD:
754.26
Share Volume:
683.45K
Regeneron Pharmaceuticals 52-Week Range
52-Week High:
1,211.20
52-Week Low:
735.95
Sell
44
Regeneron Pharmaceuticals (REGN)
is a Sell
Regeneron Pharmaceuticals Share Price Forecast
-
What is the Regeneron Pharmaceuticals stock price today?
The Regeneron Pharmaceuticals stock price is 754.26 USD today. -
Will REGN stock go up or go down?
Regeneron Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Regeneron Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Regeneron Pharmaceuticals is overvalued.
Is Regeneron Pharmaceuticals Stock a Buy?
- Regeneron Pharmaceuticals share price is 754.26 while REGN 8-day exponential moving average is 755.14, which is a Sell signal.
- The stock price of REGN is 754.26 while Regeneron Pharmaceuticals 20-day EMA is 784.37, which makes it a Sell.
- Regeneron Pharmaceuticals 50-day exponential moving average is 874.28 while REGN share price is 754.26, making it a Sell technically.
- REGN stock price is 754.26 and Regeneron Pharmaceuticals 200-day simple moving average is 958.60, creating a Sell signal.
Fundamental Analysis of Regeneron Pharmaceuticals
Is Regeneron Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $2.52 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.42 per share, and an increase next year of $0.40 per share.
Technical Analysis of Regeneron Pharmaceuticals
Should I short Regeneron Pharmaceuticals stock?
- REGN Moving Average Covergence Divergence (MACD) indicator is -42.53, suggesting Regeneron Pharmaceuticals is a Sell
- Regeneron Pharmaceuticals Relative Strength Index (RSI) is 28.68, which suggest Regeneron Pharmaceuticals is oversold
- The Bollinger Bands (25) for Regeneron Pharmaceuticals is (743.49 - 834.83), which suggest Regeneron Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Regeneron Pharmaceuticals is (865.46 - 1158.48), which suggest Regeneron Pharmaceuticals is a Sell
* Regeneron Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.